Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients
Zajac P, Heberer M, Schultz-Thater E, Padovan E, Noppen C, Guller U, Bolli M, Adamina M, Marti W, Oertli D, Spagnoli G. Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients. Hum Gene Ther 2003; 14:1497-510.
Nov 1, 2003
Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients
Nov 1, 2003
Hum Gene Ther 2003; 14:1497-510
Zajac P, Heberer M, Schultz-Thater E, Padovan E, Noppen C, Guller U, Bolli M, Adamina Michel, Marti W, Oertli D, Spagnoli G
more